The global mammography market size is expected to reach USD 4.67 billion by 2030 and is projected to grow at a CAGR of 10.50% from 2025 to 2030. The growth is mainly driven by the rising initiatives by various governments and NGOs to raise awareness about the early diagnosis of microcalcifications in breast tissue.
For instance, the National Breast Cancer Screening Programme in the Netherlands, for example, was created for women aged 50 to 75. According to the program, women in this age bracket were invited for a mammogram every two years. Similarly, in Australia, women aged 50 to 74 are required to have free mammograms every 2 years as part of the government's national screening program, Breast Screen Australia. Some other significant organizations such as the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are promoting early diagnosis of mammary gland calcification. This is one of the crucial factors expected to drive market growth.
Major mammography manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years. For instance, in March 2018, Siemens Healthineers obtained U.S. FDA approval for its enhanced mammography platform MAMMOMAT Revelation. This platform is combined with a new InSpect specimen imaging tool as well as new HD Breast Biopsy technology for one-click targeting of affected areas. Moreover, in October 2021, iCAD, Inc. launched its latest generation of ProFound AI for 2D Mammography.
Furthermore, the use of Artificial Intelligence (AI) in 3D mammography has reduced exam time while maintaining image quality. For instance, in March 2021, iCad received USFDA approval for its ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) system. Compared to previous versions of the software, it provides up to a 10% enhancement in specificity performance, up to 1% improvement in sensitivity, and offers 40% faster processing. Thus, rapid FDA approval for AI-enabled 3D mammography equipment is driving market growth.
Request a free sample copy or view report summary: Mammography Market Report
The digital systems segment dominated the market with a revenue share of more than 59.82% in 2024 and is expected to witness considerable growth over the forecast period.
The digital mammography technology segment accounted for the largest revenue share of more than 65.94% in 2024 due to the various advantages of this technology.
The hospitals end Use segment dominated the market in 2024 with a revenue share of around 45.68%.
The mammography market in North America held the largest share of 35.48% of the global revenue in 2024. The rising incidence of breast cancer in the region is one of the major factors driving the market growth.
Grand View Research has segmented the global mammography market on the basis of product, technology, end use, and region:
Mammography Product Outlook (Revenue, USD Million; 2018 - 2030)
Film Screen Systems
Digital Systems
Analog Systems
3D Systems
Mammography Technology Outlook (Revenue, USD Million; 2018 - 2030)
Breast Tomosynthesis
CAD Mammography
Digital Mammography
Mammography End Use Outlook (Revenue, USD Million; 2018 - 2030)
Hospitals
Specialty Clinics
Diagnosis Centers
Others
Mammography Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Mammography Market
Hologic Inc.
Analogic Corporation
CANON MEDICAL SYSTEMS CORPORATION
FUJIFILM Corporation
Siemens Healthcare Private Limited
Toshiba
GE HealthCare
Metaltronica S.p.A
Koninklijke Philips N.V.,
Planmed Oy
"The quality of research they have done for us has been excellent..."